Karam Khaddour

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Patients Undergoing

Squamous Cell Carcinoma

Circulating Tumor

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

Melanoma management

This page only lists publications with an associated author ORCID identifier.

Publications

Emily Y Kim, Mofei Liu, Anita Giobbie-Hurder, Furkan Bahar, Karam Khaddour, Ann W Silk, Manisha Thakuria
Patterns of initial distant metastases in 151 patients undergoing surveillance for treated Merkel cell carcinoma. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Karam Khaddour, Naoka Murakami, Emily S Ruiz, Ann W Silk
Cutaneous Squamous Cell Carcinoma in Patients with Solid-Organ-Transplant-Associated Immunosuppression. Cancers 16 (17) (2024)
Emily Y Kim, Mofei Liu, Anita Giobbie-Hurder, Furkan Bahar, Karam Khaddour, Ann W Silk, Manisha Thakuria
Patterns of initial distant metastases in 151 patients undergoing surveillance for treated Merkel cell carcinoma. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (6) (2024)
Zein Alabdin Hannouneh, Amjad Hijazi, Alaa Aldeen Alsaleem, Siwan Hami, Nina Kheyrbek, Fadi Tanous, Karam Khaddour, Abdulfattah Abbas, Zuheir Alshehabi
Novel immunotherapeutic options for BCG-unresponsive high-risk non-muscle-invasive bladder cancer. Cancer medicine (2023)
Alexander Willis, Seth J Corey, Carlos Murga-Zamalloa, Saman Karimi, Karam Khaddour, John G Quigley, Elizabeth A Eklund, Yolande Chen
Dynamin-2 deficiency causes age- and sex-dependent neutropenia and myelodysplasia in mice. Blood advances (2022)
Helen Hwang, Jiayi Huang, Karam Khaddour, Omar H Butt, George Ansstas, Jie Chen, Ruth Gn Katumba, Albert H Kim, Eric C Leuthardt, Jian L Campian
Prolonged response of recurrent IDH -wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab. CNS oncology 11 (1) (2022)
Karam Khaddour, Manuel Felipe Fernandez, Marsel Khabibov, Airat Garifullin, Danielle Dressler, Iuliia Topchu, Jyoti D Patel, Frank Weinberg, Yanis Boumber
The Prognostic and Therapeutic Potential of DNA Damage Repair Pathway Alterations and Homologous Recombination Deficiency in Lung Cancer. Cancers 14 (21) (2022)
Karam Khaddour, Tanner M Johanns, George Ansstas
BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma. Melanoma management 8 (2) (2021)
Karam Khaddour, Michael Ansstas, George Ansstas
Clinical outcomes and longitudinal circulating tumor DNA changes after treatment with nivolumab and olaparib in immunotherapy relapsed melanoma with detected homologous recombination deficiency. Cold Spring Harbor molecular case studies 7 (5) (2021)
Jing Xi, Bilal Hassan, Ruth G N Katumba, Karam Khaddour, Akshay Govindan, Jingqin Luo, Jiayi Huang, Jian L Campian
The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma. BMC cancer 21 (1) (2021)
Karam Khaddour, Ilana S Rosman, Farrokh Dehdashti, George Ansstas
Durable remission after rechallenge with ipilimumab and nivolumab in metastatic Merkel cell carcinoma refractory to avelumab: Any role for sequential immunotherapy? The Journal of dermatology 48 (2) (2020)
Karam Khaddour, Tanner M Johanns, George Ansstas
The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions. Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)
Karam Khaddour, Veerpal Singh, Maryna Shayuk
Acral vascular necrosis associated with immune-check point inhibitors: case report with literature review. BMC cancer 19 (1) (2019)
Karam Khaddour, Amy Musiek, Lynn A Cornelius, Farrokh Dehdashti, Peter Westervelt, Ryan Fields, George Ansstas
Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome. Journal for immunotherapy of cancer 7 (1) (2019)